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BreastAbstract Purpose: To evaluate the role of dynamic contrast enhanced magnetic resonance
imaging in differentiation between benign postoperative changes and recurrent malignant tumor.
Patients & methods: This study was performed during the time from August 2014 till August 2015.
Enrolled in this study were 50 female patients and all of them were breast cancer patients that had
been candidates for breast conserving surgery, modiﬁed radical mastectomy and reconstructive sur-
gery using autologous tissue reconstruction; DCE-MRI was done for all patients.
Results: In this study, 12 patients (24%) were with recurrent malignant tumor, 7 patients (14%)
with postoperative fat necrosis, 10 patients (20%) with postoperative seroma, 10 patients (20%)
with diffuse skin thickening and edema, and 6 patients (12%) with postoperative scar tissue; the
remaining 5 patients (10%) were normal. Dynamic contrast enhanced MRI has sensitivity of
85.7%, speciﬁcity of 100%, PPV of 100%, NPV of 93.3% and accuracy of 95.6% in differentiation
between benign postoperative changes and recurrent malignant tumors.
 2016 The Egyptian Society of Radiology andNuclearMedicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Preventing local recurrence in women who undergo breast con-
serving therapy or mastectomy is important because local
recurrence is associated with increased cost, psychological dis-
tress, and potentially worse prognosis of the disease (1).
Presence of cancer cells in the vicinity of the primary tumor
after resection in period between 3 and 12 months is more
likely a residual tumor. Most doctors consider cancer to berecurrence if there were no signs of cancer for at least 2 years
(2).
Architectural distortion and increased density at the
lumpectomy site as well as post-treatment edema may impair
accurate detection of recurrence at mammography and ultra-
sonography (US) (3).
Dynamic contrast-enhanced magnetic resonance imaging
(DCE-MR) has been shown to aid signiﬁcantly in detection
and characterization of primary and recurrent breast cancers
(4). The most important factor is that MRI can assess both
lesion morphology and enhancement kinetics (5).
The sensitivity of breast MR imaging for detection of resid-
ual and recurrent tumor in the post-breast conservative ther-
apy (BCT) is over 90% (6). Breast MR imaging has been
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recurrence; in particular, non-enhancing areas have a high neg-
ative predictive value for malignancy (88–96%) (7,8).
The aim of the study was to evaluate the role of dynamic
contrast enhanced magnetic resonance imaging in differentia-
tion between benign postoperative changes and recurrent
malignant tumors.
2. Patients & methods
This study was performed during the time from August 2013
till August 2015. Enrolled in this study were 50 female patients
who underwent prior surgery for malignant breast lesions and
are suspected to have local regional recurrence. 25 patients
underwent breast conserving surgery (lumpectomy versus
quadrantectomy), 12 patients underwent modiﬁed radical mas-
tectomy and 13 patients underwent reconstructive surgery
using autologous tissue reconstruction.
Their age range was 30–70 years with a mean age of
50.98 years. The indication for referral to our MRI unit in
Mansoura university hospital was diffuse breast enlargement
in 15 patients, palpable lump in 24 patients, and routine post-
operative follow-up (6 months up to 2 years post-surgery) in 11
patients.
Exclusion criteria were as follows:
Patients who have contraindications to do MRI as patients
with cardiac pacemaker, and patients with cochlear implant
and ocular foreign body.
3. Methods
All patients underwent full history taking, general and local
examination.
3.1. Mammography and complementary ultrasound examination
Mammography was performed for 38 patients, including both
Cranio caudal (CC) and medio lateral (ML) views. Cases with
modiﬁed radical mastectomy could not handle breast compres-
sion elicited during mammography examination.
High resolution conventional ultrasound was performed for
50 patients by 8–12 MHz linear array transducer.
3.2. MR imaging
In 50 patients, MRI of the breast was performed on supercon-
ducting 1.5 T MR imaging unit (Philips Ingenia). All patients
were examined in the prone position using dedicated breast
coil.
4. MRI protocol
The following protocol was applied for all patients.
A. Localizing sagittal protocol (scout view)
B. T1-weighted pulse sequence
Axial non-fat saturated TIWI was obtained by FSE with
the following imaging parameters: TR 450 ms, TE 14 ms, slicethickness 3 mm, ﬁeld of view (FOV) 300–360 mm and matrix
was 307  512.
C. T2-weighted pulse sequence
Axial non-fat-suppressed T2-weighted turbo spin-echo was
obtained with the following parameters TR 4500, TE 97,
matrix 384  512 and slice thickness 3 mm.
D. Short TI inversion recovery (STIR)
Axial STIR was obtained with the following parameters:
TR 7000–9000 ms, TE 70 ms and inversion time (TI) was
150 ms, slice thickness was 3–4 mm with inter-slice gap
1 mm, ﬁeld of view (FOV) 300–360 mm and the matrix was
307  512.
E. Dynamic study
All dynamic studies were made in the axial plane with fat
suppression by applying fat saturated pulse. The sequence used
was FLASH 3-D GRE-T1WI with the following parameters:
TR 4–8 ms, TE 2 ms, ﬂip angle 20–25, slice thickness 2 mm
with no inter-slice gap, FOV 300–360 mm and the matrix
was 307  512. Dynamic contrast enhanced MRI was per-
formed after injection of a bolus of gadopentetate dimeglu-
mine, in a dose of 0.2 m-mol/kg using an automated injector
at a rate of 3–5 ml/s through a 18–20 gauge intravenous can-
nula inserted in an ante-cubital vein. This was followed by a
bolus injection of saline (total of 20 ml at 3–5 ml/s).
Dynamic study consists of one pre-contrast and 5 post-
contrast series, each of them took about 1.16 min with a break
between the pre-contrast and post-contrast study about 20 s.
5. Image post-processing
Image post-processing includes image subtraction which was
obtained by subtracting each of the pre-contrast images from
each post-contrast series images, creation of time to signal
intensity curve for suspicious enhancing lesions and maximum
intensity projection (MIP) views obtained through each
orthogonal plane, producing sagittal, coronal and axial
projection.
5.1. Image analysis
STIR images were ﬁrst examined to detect edema, postopera-
tive seroma and hematoma. T1WI was also examined to detect
fat within the lesion.
6. Morphological analysis
Lesions were classiﬁed as a mass, an area of non-mass-like
enhancement or a focus.
6.1. Mass
A mass is a three-dimensional, space-occupying lesion. It is
usually visible on pre-contrast T1 or T2 weighted images.
Diagram B Type II curve (19).
Evaluation of post-operative breast lesions 633Masses were described in terms of shape, margin, and internal
enhancement characteristics.
6.2. Non-mass-like enhancement
Non-mass-like enhancement refers to enhancement of an area
that was neither a mass nor a focus. Non-mass-like enhance-
ment was categorized by distribution, internal enhancement
pattern, and symmetric or asymmetric enhancement.
7. Analysis of enhancement kinetics
Considering the contrast enhancement pattern during the
dynamic series, three different phases were distinguished.
(1) The early phase (between contrast injection and the sec-
ond post-contrast phase).
(2) The post-initial phase (3rd to 4th post-contrast phase).
(3) The late phase (later than the 4th post-contrast phase).
Types of curve were deﬁned according to delayed phase
enhancement as persistent Type I curve (Diagram A) (contin-
uous increase in signal intensity on each successive contrast
enhanced images), plateau Type II curve (Diagram B) (initial
increase in signal intensity is followed by a ﬂattening of the
enhancement curve), and washout Type III curve (Diagram C)
(initial increase and subsequent decrease in signal intensity).
8. Standard of reference
The possible pathology suggested by MR imaging to be resid-
ual malignancy had been correlated with biopsy. For suggested
benign post-operative changes, regressive course and/or com-
plete resolution of the condition after follow-up every three
months for two years duration by sonomammography and
dynamic contrast enhanced MRI was the standard of
reference.Diagram A Type I curve (19).
Diagram C Type III curve (19).9. Statistical analysis
Inter-group comparison of categorical data was performed
by using chi-square test (X2-value). The sensitivity, speci-
ﬁcity, positive predictive value, negative predictive value
and accuracy of MRI were calculated to differentiate
between benign postoperative changes and recurrent malig-
nant lesions. Data were analyzed using the computer pro-
gram SPSS (Statistical package for social science) version
17.0. A P value <0.05 was considered statistically signiﬁ-
cant. P value of <0.0001 was considered highly signiﬁcant
in all analyses.
Fig. 1b Axial STIR image showing diffuse skin thickening of the
left breast, mild interstitial edema and lesion of low signal intensity
in the lower inner quadrant of the left breast.
Fig. 1c Axial 2nd minute post-contrast subtraction image
showing heterogeneously enhancing lesion in the lower inner
quadrant of the left breast.
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10.1. Case No: 1
Female patient aged 40 years with history of left breast cancer
and underwent lumpectomy, now presented by palpable lump
(see Figs. 1a–1e).
MRI ﬁndings are consistent with postoperative fat necrosis.
Truecut biopsy revealed postoperative fat necrosis.
10.2. Case No: 2
Female patient aged 43 years with history of left breast cancer
underwent lumpectomy and presented by palpable mass in the
left breast (see Figs. 2a–2d).
This case was categorized by MRI as BI-RADS 5 proved to
be recurrent grade III inﬁltrating duct carcinoma.
10.3. Case No: 3
Female patient aged 42 years with history of right breast intra-
ductal carcinoma, presented by palpable lump (see Figs. 3a–
3d).
MRI ﬁndings of this case are consistent with post-operative
seroma and categorized as BI-RADS 2. By follow-up of this
case total resolution of seroma was observed after 6 months.
10.4. Case No: 4
Female patient aged 40 years with history of invasive duct car-
cinoma underwent lumpectomy and now presented by diffuse
breast enlargement (see Figs. 4a–4d).
This case was categorized by MRI as BI-RADS 4C and
biopsy revealed recurrent ductal carcinoma.
11. Results
Fifty female patients with prior surgery for breast cancer were
enrolled in this prospective study with age range of 30–70 years
(mean age of 50.98 years).
Concerning the type of surgery, 25 patients have had breast
conserving surgery (lumpectomy and quadrantectomy), 12
patients had modiﬁed radical mastectomy and 13 patientsFig. 1a Axial T1WI showing lesion of high signal intensity in the
lower inner quadrant of the left breast.
Fig. 1d Axial 4th minute post-contrast subtraction image shows
progressive pattern of enhancement (persistent time signal inten-
sity curve).had reconstructive surgery using autologous tissue
reconstruction.
The indication for referral to our MRI unit in Mansoura
university hospital was diffuse breast enlargement in 15
patients, palpable lump in 24 patients, and routine postopera-
Fig. 1e Time intensity curve showing mild initial enhancement
with progressive pattern of enhancement (Type I curve).
Fig. 2b Axial early 2nd minute post-contrast subtraction images
showing the spiculated mass in the lower outer quadrant of the left
breast inﬁltrating the skin, and it shows initial rapid degree of
heterogeneous enhancement.
Fig. 2c Axial 4th minute post-contrast subtraction image
showing washout pattern of enhancement (washout time signal
intensity curve).
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patients (Table 6).
Mammography was done for 38 patients, and the remain-
ing 12 patients had previous modiﬁed radical mastectomy
and therefore couldn’t handle breast compression elicited dur-
ing mammography examination. Complementary ultrasound
was done for all patients.
In this study, 12 patients (24%) were with recurrent malig-
nant tumor, 7 patients (14%) with postoperative fat necrosis,
10 patients (20%) with postoperative seroma, 10 patients
(20%) with diffuse skin thickening and edema, and 6 patients
(12%) with postoperative scar tissue; the remaining 5 patients
(10%) were normal. Our results were conﬁrmed by
histopathology for suspicious malignant lesions by MRI andFig. 2a Axial STIR MRI image shows increased skin thickness
and edema of the left breast.regular follow-up every three months for suspected benign
lesions.
Dynamic contrast enhanced MRI was performed for 50
patients, and both lesion morphology and enhancement kinet-
ics were assessed to differentiate between benign postoperative
changes and recurrent malignant tumor.
Thirty patients had mass lesions on dynamic contrast
enhanced MRI and according to the margins of the lesion
(Table 1), eleven patients had masses with speculated margins
and six out of them were proved pathologically to have recur-
rent malignant tumors while the remaining ﬁve patients proved
to have postoperative scarring, so the spiculated margin has
50% sensitivity and 89% speciﬁcity for detection of malignant
lesions and it is considered statistically highly signiﬁcant differ-
ence between benign and malignant lesions with P value
0.0001. Eleven patients had masses with regular smooth mar-
gins, nine of them were proved to have postoperative seroma
and the other two patients were proved to have postoperative
fat necrosis, so regular smooth margin has 100% sensitivity
and 100% speciﬁcity for detection of benign lesions. Irregular
margins were found in eight patients, ﬁve of them were proved
to have postoperative fat necrosis, one patient proved patho-
logically to have postoperative ﬁbrosis, while the remaining
Fig. 2d Time intensity curve showing initial rapid enhancement
of the lesion with subsequent washout (Type III curve).
Fig. 3a Axial STIR MRI image shows increased skin thickness
and edema of the right breast with a well deﬁned lesion of high
signal intensity in the lower outer quadrant of the right breast.
Fig. 3b Axial 2nd minute post-contrast T1WI with fat suppres-
sion showing thin rim of enhancement (<5 mm).
Fig. 3c Axial 4th minute post-contrast T1WI with fat suppres-
sion showing progressive pattern of enhancement (Type I time
signal intensity curve).
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so irregular margins have 60% sensitivity and 87.5% speci-
ﬁcity for detection of malignant lesions.
Thirty-one patients showed contrast enhancement on
dynamic MRI study, according to the pattern of enhancement
(Table 2), and 11 patients have masses with smooth marginal
enhancement, 9 of them were proved to have postoperative
seroma and the other 2 patients were proved to have postoper-
ative fat necrosis, so smooth marginal enhancement has 100%
sensitivity and 100% speciﬁcity for detection of benign lesions.
Heterogeneous enhancement was found in 15 patients, 8 of
them were proved to have recurrent malignant tumors, 2
patients were proved pathologically to have postoperative
ﬁbrosis, while the remaining 5 patients were proved to have
postoperative fat necrosis, so heterogeneous enhancement
has 66.6% sensitivity and 83.3% speciﬁcity for detection ofmalignant lesions and it is considered statistically signiﬁcant
difference between benign and malignant lesions with P value
0.0.02. 19 patients have no enhancing lesions; all of them were
proved to be free from recurrent malignant tumors, MRI study
for 5 of them was totally normal, 10 patients have diffuse skin
thickness and edema, and the remaining 4 patients were
proved pathologically to have postoperative scar, so non-
enhancing lesions have 100% sensitivity and 100% speciﬁcity
for detection of benign lesions. Five patients had non-mass like
enhancement, and one of them showed small focal area of non-
mass-like enhancement at the lumpectomy site. By follow-up
of this patient for 1 year by dynamic contrast enhanced MRI
no mass was developed and the non-mass-like enhancement
shows stationary course along this year. The MRI study for
remaining 4 patients shows area of clumped non-mass-like
enhancement and biopsy from these lesions revealed recurrent
ductal carcinoma.
According to the presence of fat on T1WI (Table 3), 7
patients were proved pathologically to have fat necrosis, all
of them have high signal intensity on T1WI.
According to the type of kinetic curve (Table 4), Type I
curve was noted in 15 patients and all of them were benign
postoperative changes as postoperative seroma and fat necro-
sis, so Type I curve has sensitivity and speciﬁcity of 100% for
Fig. 3d Time intensity curve showing mild initial enhancement
with progressive pattern of enhancement (Type I curve).
Fig. 4a Axial STIR MRI image shows increased skin thickness
and edema of the left breast.
Fig. 4b Axial post-contrast T1WI with fat suppression showing
area of clumped non-mass-like enhancement seen in the lower
outer quadrant of the left breast.
Fig. 4c Axial 4th minute post-contrast T1WI with fat suppres-
sion shows washout pattern of enhancement.
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had benign postoperative changes (postoperative fat necrosis
and ﬁbrosis), while the remaining 3 patients were recurrent
malignant tumor, so Type II curve has 25% sensitivity and
72% speciﬁcity for detection of malignant lesions. Type III
curve was noted in 10 patients, 9 of them were proved to be
recurrent malignant tumor and the remaining 1 patient was
proved to have postoperative ﬁbrosis, so Type III curve has
75% sensitivity and 97% speciﬁcity for detection of malignant
lesions and it is considered statistically highly signiﬁcant differ-ence between benign and malignant lesions with P value
0.0001.
The most sensitive and speciﬁc parameters for detection of
recurrent malignant tumors are heterogeneous enhancement
and Type III curve.
The most sensitive and speciﬁc parameters for detection of
benign postoperative changes as scar tissue and fat necrosis are
the absence of enhancement and presence of fat on T1WI.
Finally dynamic contrast enhanced MRI has sensitivity of
85.7%, speciﬁcity of 100%, PPV of 100%, NPV of 93.3%
and accuracy of 95.6% in differentiation between benign post-
operative changes and recurrent malignant tumors (Table 5).
12. Discussion
MR imaging is useful in evaluation of the postoperative breast,
as distortion of normal breast architecture can confound the
physical examination and the mammographic assessment of
the breast. This leads to difﬁculty in distinguishing between
normal postsurgical changes and locally recurrent breast can-
cer (9).
Fig. 4d Time intensity curve showing initial rapid enhancement
of the lesion with subsequent washout (Type III curve).
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between benign postoperative ﬁndings and recurrent breast
cancer (3). The most important factor of MR imaging in differ-
entiation between neoplasia and post-treatment changes is the
integration of lesion morphology and enhancement kinetics
following administration of gadolinium contrast material
(10). Breast cancers, whether primary or recurrent, will typi-
cally demonstrate early and rapid contrast enhancement kinet-
ics, often with delayed washout. Benign postoperative changes,
such as ﬁbrosis or fat necrosis, will generally demonstrate more
gradual uptake of contrast material (11).
Postoperative seromas are common following breast sur-
gery; in this study MRI for 10 patients (20%) showed postop-
erative seromas, all of them have high signal on STIR images,
regular smooth margins, showing thin smooth marginal
enhancement and Type I time signal intensity curve and this
is in agreement with several studies (3,9) which stated thatTable 1 Shows correlation between the margins of the lesion and d
Margin of the lesions Groups
Normal Benign
Irregular No 0 6
% 0.0% 18.2%
Regular No 0 11
% 0.0% 33.0%
Spiculated No 0 5
% 0.0% 15.2%
Total No 5 33
% 100.0% 100.0%
X2-value is chi-square test used for inter-group comparison of categorica
P value is probability factor value.postoperative seromas have high signal intensity (ﬂuid signal)
on T2-weighted images and Smooth, thin (65 mm) rim
enhancement.
Fat necrosis is a common and challenging pitfall in inter-
pretation of post-breast conservative surgery and MR imag-
ing. However, when identiﬁed appropriately, this ﬁnding can
be placed in the BI-RADS 2 or BI-RADS 3 category. The mar-
gins and the enhancement pattern of fat necrosis may be indis-
tinguishable from recurrent malignant tumor. The clue for the
diagnosis of postoperative fat necrosis is the presence of fat on
T1WI (3,12).
In 2015 Mansour and Behairy (13), performed prospective
study about the role of diffusion weighted MRI (DWI) in post-
operative breast and they declared that the application of pre-
contrast non-fat saturation T1WI had a very important role in
the assessment of postoperative breast lesions mimicking
malignant lesions (fat necrosis or fat engulfed scar tissue). In
our work high signal on T1WI (fat signal intensity) was present
in 7 cases which were proved pathologically to be fat necrosis.
Fibrosis is a common sequela of radiation therapy in the
breast. Fibrotic masses can be irregular in appearance, often
with spiculated margins (14). Distortion of the surrounding
breast architecture can also be seen. These ﬁndings overlap
with those of cicatrizing tumors. One of the challenges in eval-
uating the postoperative breast is therefore the differentiation
between postoperative or post-radiation therapy scarring and
tumor recurrence (9).
Previous studies (3,9) stated that MR imaging has been
shown to be useful in differentiating scar tissue from tumor
recurrence; in particular, non-enhancing areas have a high neg-
ative predictive value for malignancy (88–96%). In our study 6
cases were proved pathologically to be postoperative scarring;
in 4 of them, MRI showed an area of architectural distortion
and no enhancement was observed on dynamic post-contrast
study, and the remaining 2 cases were misdiagnosed by MRI
to be recurrent malignant tumor as one of them showed spic-
ulated margin, heterogeneous enhancement and Type II time
signal intensity curve, and the other case showed irregular
margin, heterogeneous enhancement and Type III time signal
intensity curve.
In the current study we had 5 patients with non-mass-like
enhancement, and one of them showed small focal area of
non-mass-like enhancement at the lumpectomy site with Typeetection of recurrent malignant tumor.
Total P X2 P
Malignant
2 8 0.37 31.5 <0.0001
16.6% 16.0%
0 11 0.075
0.0% 22.0%
6 11 0.001
50.0% 22.0%
12 50
100.0% 100.0%
l data.
Table 2 Shows correlation between the pattern of enhancement and detection of recurrent malignant tumor.
Pattern of enhancement Groups Total P X2 P
Normal Benign Malignant
Heterogeneous enhancement No 0 7 8 15 0.028 30.3 <0.0001
% 0.0% 21.2% 66.7% 30.0%
Marginal enhancement No 0 11 0 11 0.075
% 0.0% 33.0% 0.0% 22.0%
No enhancing lesions No 5 14 0 19 0.027
% 100.0% 42.2% 0.0% 38.0%
Non-mass-like enhancement No 0 1 4 5 0.16
% 0.0% 3.0% 33.3% 10.0%
Total No 5 33 12 50
% 100.0% 100.0% 100.0% 100.0%
X2-value is chi-square test used for inter-group comparison of categorical data.
P value is probability factor value.
Table 3 Shows correlation between the presence of fat on
T1WI and detection of recurrent malignant tumor.
Presence of fat on
T1WI
Groups Total
Normal Benign Malignant
Absent No 5 26 12 43
% 100.0% 78.8% 100.0% 86.0%
Present No 0 7 0 7
% 0.0% 21.2% 0.0% 14.0%
Total No 5 33 12 50
% 100.0% 100.0% 100.0% 100.0%
Table 5 Shows sensitivity, speciﬁcity, PPV, NPP and accu-
racy of dynamic contrast enhanced MRI in detection of
recurrent malignant tumors.
Sensitivity Speciﬁcity PPV NPV Accuracy
MRI 85.7 100.0 100.0 93.3 95.6
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2 years by dynamic contrast enhanced MRI revealed that no
cancer was developed and the non-mass-like enhancement
shows stationary course along this year. Several references
(3,15) stated that a minimal or small focal area of enhancement
or thin linear non-mass-like enhancement (NMLE) can be seen
for up to 18 months (in some cases even longer) without nodu-
larity or an associated mass and they consider it probably
benign and appropriate for 6-month MR imaging follow-up.Table 4 Shows correlation between type of kinetic curve and detec
Kinetic curve assessment Groups
Normal Benign Ma
Type I No 0 15 0
% 0.0% 45.4% 0.0%
Type II No 0 3 3
% 0.0% 9.0% 25.0
Type III No 0 1 9
% 0.0% 3.0% 75.0
Total No 5 33 12
% 100.0% 100.0% 100
X2-value is chi square test used for inter-group comparison of categorica
P value is probability factor value.In the current study, 4 patients had area of clumped non-
mass-like enhancement at MRI, 2 of them showed Type II
time signal intensity curve and the remaining 2 cases showed
Type III time signal intensity curve. Biopsy from these lesions
revealed recurrent ductal carcinoma. Several publications
(3,9,12) reported that ductal and clumped non-mass-like
enhancement has high positive predictive values for malig-
nancy of up to 85% and 60%, respectively.
Petralia (2011) and Drukteinis (2012) (3,16) stated that
recurrent malignant lesions showed rapid enhancement follow-
ing administration of gadolinium contrast material. Other fea-
tures, such as heterogeneous enhancement and spiculated
margins increase the likelihood of malignancy, comparable
with our results; 8 patients proved pathologically to have
recurrent breast cancer, their MRI study showed masses withtion of recurrent malignant tumor.
Total P X2 P
lignant
15 0.02 50.57 <0.0001
30.0%
6 0.2
% 12.0%
10 <0.0001
% 20.0%
50
.0% 100.0%
l data.
Table 6 Shows correlation between clinical ﬁndings and ﬁnal diagnosis in ﬁfty female patients included in study.
Clinical ﬁnding Final diagnosis
Fat
necrosis
Seroma Recurrent malignant
tumor
Diﬀuse skin thickening and
edema
Postoperative
scar
Normal Total
Diﬀuse breast
enlargement
No 1 3 10 1 15
% 6.6% 20% 66.66% 6.6%
Palpable lump No 7 9 7 1 24
% 29.16% 37.5% 29.16% 4.16%
Postoperative follow-
up
No 2 4 5 11
% 18.18% 36.36% 45.45%
640 M.A. EL-Adalany, E.E.-D. Hamedspeculated margins and heterogeneous enhancement, 7 of them
showed Type III time signal intensity curve and 1 case showed
Type II time signal intensity curve.
In our work DCE-MRI yielded sensitivity (85.7%), speci-
ﬁcity (100%) and accuracy (95.6%) in diagnosis of recurrent
malignant tumor. There is a large series of papers in the liter-
ature (3,9,15,17,18) stated that breast MRI has a high sensitiv-
ity in the detection of breast cancer and, in particular, a high
sensitivity and speciﬁcity in differentiating scar from recurrent
tumor.
13. Conclusion
Dynamic contrast enhanced MRI is a valuable tool in evalua-
tion of postoperative breast as it has high sensitivity and speci-
ﬁcity in differentiation between benign postoperative changes
and recurrent malignant tumor. Breast MRI minimizes unnec-
essary intervention and optimizes diagnosis of recurrence in its
early stages.
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